Loading the chart…
| Outcome | Chance | 24h | 1 week | Bid · Ask | 24h volume | Ends |
|---|---|---|---|---|---|---|
| Yes | 3% | 0 pts | +1 pts | 3¢ · 3¢ (<1¢) | $79.3 | in 76d |
| When | Trader | Outcome | Bet | Size | P&L now | Insider |
|---|---|---|---|---|---|---|
| 34d | Darling-Top | Hantavirus vaccine in 2026? | BuyNo95¢ → 97¢ | $2,468 | +$48 +1.9% | 7 |
| 103d | Bustling-Raid | Hantavirus vaccine in 2026? | SellNo94¢ → 97¢ | $1,286 | −$39 −3.0% | — |
| 106d | Bustling-Raid | Hantavirus vaccine in 2026? | BuyNo95¢ → 97¢ | $1,300 | +$25 +1.9% | 7 |
| 163d | Laurenman | Hantavirus vaccine in 2026? | SellNo91¢ → 97¢ | $2,375 | −$153 −6.4% | — |
| 163d | Hantavirus vaccine in 2026? | BuyNo92¢ → 97¢ | $2,668 | +$141 +5.3% | 9 | |
| 164d | Hantavirus vaccine in 2026? | SellNo91¢ → 97¢ | $1,820 | −$117 −6.4% | — | |
| 164d | Hantavirus vaccine in 2026? | SellNo91¢ → 97¢ | $1,820 | −$117 −6.4% | — | |
| 164d | whitetofu2 fills | Hantavirus vaccine in 2026? | BuyNo92¢ → 97¢ | $2,000 | +$105 +5.3% | 9 |
| 165d | Laurenman | Hantavirus vaccine in 2026? | BuyNo93¢ → 97¢ | $1,212 | +$50 +4.1% | 9 |
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Sources: Polymarket's Gamma API, its CLOB price history and its Data API, read every two minutes. Prices are each outcome's Yes price, which is the market's probability: 3¢ for Yes means the market gives it about 3%.